| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/02/1992 | CA1302651C Fsh-releasing peptide |
| 06/02/1992 | CA1302321C2 Preparation of polypeptides |
| 05/31/1992 | WO1992010760A1 Methods for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | WO1992009631A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2097426A1 Method for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | CA2097309A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/31/1992 | CA2056564A1 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 05/31/1992 | CA2056261A1 Antibody reactive to hamster immunoglobulins |
| 05/29/1992 | WO1992008982A1 Characterization of platelet aggregation disorders |
| 05/29/1992 | WO1992008802A1 Bispecific antibodies, method of production, and uses thereof |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008740A2 Receptor recognition factor and methods of use thereof |
| 05/29/1992 | WO1992008738A1 Monoclonal antibodies to hepatitis c virus and method for using same |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992006199A3 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/29/1992 | CA2056222A1 Peptide compound, pharmaceutical composition and feed additive for animal |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487301A1 Method of stabilizing enzyme conjugates |
| 05/27/1992 | EP0487298A2 Human gamma interferon antagonist/agonist screen |
| 05/27/1992 | EP0487229A1 A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene |
| 05/27/1992 | EP0487099A2 Bacteriorhodopsine - double mutants |
| 05/27/1992 | EP0486908A2 TNF-Muteins |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486861A1 Active fragments of fibroblast growth factor |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | DE4037196A1 Verfahren zur reaktivierung von denaturiertem protein A process for the reactivation of denatured protein |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116951 Substantially pure interleukin-9 receptor and uses thereof |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | US5116942 Protein having an inflammatory phospholipase a2 inhibitory activity |
| 05/26/1992 | US5116816 Immunosuppressants, antiinflammatory, parasiticides |
| 05/26/1992 | US5116815 Pf 1022 substance, method of treating helminthic parasitic infection and anthelmintic composition |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | US5116749 γ-glutamylcysteine transferase |
| 05/26/1992 | US5116747 Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate |
| 05/26/1992 | US5116741 Biosynthetic uses of thermostable proteases |
| 05/26/1992 | US5116724 Products for separation applicable to cells in the immunopurification field |
| 05/26/1992 | CA1301689C Method for selectively increasing the ratio of single major components ofantibiotic a 16686 complex |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/26/1992 | CA1301676C Genetic expression of somatostatin as hybrid polypeptide |
| 05/26/1992 | CA1301675C Polycistronic expression vector construction |
| 05/26/1992 | CA1301674C Pseudorabies virus recombinants and their use in the production of proteins |
| 05/24/1992 | CA2055961A1 Active fragments of fibroblast growth factor |
| 05/23/1992 | WO1992009622A1 Process for reactivating denatured protein |
| 05/22/1992 | CA2055168A1 Tnf-muteins |
| 05/21/1992 | CA2055812A1 Method of stabilizing enzyme conjugates |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486193A2 A method for altering post-translational processing of tissue plasminogen activator |
| 05/20/1992 | EP0486170A1 Baculoviral expression system comprising procaryotic leader sequence |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0486011A2 Pharmaceutical composition against Pneumocystis carinii |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485689A1 Cells growing in protein-free medium, and enhancing replication of exogenous genes |
| 05/20/1992 | EP0485608A1 Method for obtaining polypeptides in a cell-free translation system |
| 05/20/1992 | EP0485525A1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin. |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0485380A1 Immunological use of microwaves |
| 05/20/1992 | EP0401369A4 Method for preparative expression of genes in a cell-free system of conjugated transcription/translation |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
| 05/20/1992 | EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/19/1992 | US5115097 Synthetic peptide from the carboxy terminal of human Mn-superoxide dismutase |
| 05/19/1992 | US5115096 Amphiregulin: a bifunctional growth modulating glycoprotein |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/19/1992 | CA1301094C Bacillus thuringiensis crystal protein gene toxin segment |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007950A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | WO1992007940A2 Bovine respiratory syncytial virus genes |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |